Development of low-cost in-house CYP2C9/VKORC1 gene polymorphism assay and assess the clinical utility of CYP2C9/VKORC1 genotyping to guide personalized anticoagulant therapy in patients with atrial fibrillation as well as cardiac valve replacement
Other
Agency: Department of Bio-TechnologyRole: Other
No Data Found
There is currently nothing to display here.
No Data Found
There is currently nothing to display here.
Scholarly Publications
Substantiation of a clopidogrel metabolism-associated gene (CYP2C19) variation among healthy individuals